• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌的超声造影特征:新视角。

Contrast-enhanced Ultrasound Features of Intrahepatic Cholangiocarcinoma: A New Perspective.

机构信息

Department of Ultrasound, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.

Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.

出版信息

Sci Rep. 2019 Dec 18;9(1):19363. doi: 10.1038/s41598-019-55857-6.

DOI:10.1038/s41598-019-55857-6
PMID:31852947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6920428/
Abstract

The objective of this study was to illustrate our specific findings for intrahepatic cholangiocarcinoma (ICC) lesions on contrast-enhanced ultrasound (CEUS). In this study, 21 patients at our hospitals with pathologically proven ICC and CEUS data were retrospectively enrolled. General clinical data of the patients, and features of lesions on conventional and contrast-enhanced ultrasound were recorded. Two experienced radiologists retrospectively reviewed all images by consensus. On gray-scale sonography, hypoechoic, isoechoic and hyperechoic lesions accounted for 85.7%, 9.5% and 4.8%, respectively, of all lesions. Hypovascular patterns were found for 95.2% of the lesions on color Doppler flow imaging. During the arterial phase of CEUS, heterogeneous hyperenhancement, homogeneous hyperenhancement, rim-like hyperenhancement, isoenhancement and hypoenhancement were observed for 61.9%, 19.0%, 9.5%, 4.8%, 4.8% of the lesions, respectively. During the portal venous and late phases, 85.7% and 95.2% of the lesions, respectively, exhibited hypoenhancement. In addition, 66.7% of the ICC lesions exhibited washed-out interiors but little decrease in enhancement at the periphery during the portal venous phase, resulting in the formation of a hyperenhanced peripheral rim. In conclusion, the rim sign in the portal venous phase of CEUS could help diagnose ICC. This trait could be related to the infiltrating growth pattern of ICC.

摘要

本研究旨在展示我们在对比增强超声(CEUS)中对肝内胆管癌(ICC)病变的具体发现。本研究回顾性纳入了我院 21 例经病理证实为 ICC 且具有 CEUS 数据的患者。记录了患者的一般临床资料和常规及对比增强超声上的病灶特征。两位有经验的放射科医生通过共识对所有图像进行了回顾性分析。在灰阶超声上,所有病灶中低回声、等回声和高回声分别占 85.7%、9.5%和 4.8%。彩色多普勒血流成像上 95.2%的病灶表现为低血流模式。在 CEUS 的动脉期,分别有 61.9%、19.0%、9.5%、4.8%和 4.8%的病灶表现为不均匀高增强、均匀高增强、边缘样高增强、等增强和低增强。在门静脉期和延迟期,分别有 85.7%和 95.2%的病灶表现为低增强。此外,66.7%的 ICC 病灶在门静脉期表现为内部洗脱,但周边增强程度下降较小,形成高增强的边缘环。总之,CEUS 门静脉期的边缘环征象有助于 ICC 的诊断。这种特征可能与 ICC 的浸润性生长模式有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/9a605e3bee51/41598_2019_55857_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/85a9ea4cab2b/41598_2019_55857_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/6f0d19ea7d99/41598_2019_55857_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/1213300c65b7/41598_2019_55857_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/9a605e3bee51/41598_2019_55857_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/85a9ea4cab2b/41598_2019_55857_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/6f0d19ea7d99/41598_2019_55857_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/1213300c65b7/41598_2019_55857_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f740/6920428/9a605e3bee51/41598_2019_55857_Fig4_HTML.jpg

相似文献

1
Contrast-enhanced Ultrasound Features of Intrahepatic Cholangiocarcinoma: A New Perspective.肝内胆管癌的超声造影特征:新视角。
Sci Rep. 2019 Dec 18;9(1):19363. doi: 10.1038/s41598-019-55857-6.
2
Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.肝内胆管癌的增强模式:超声造影与CT增强扫描的比较
Br J Radiol. 2008 Nov;81(971):881-9. doi: 10.1259/bjr/22318475.
3
Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.超声造影在鉴别肝细胞癌和胆管细胞癌中的应用。
Ultraschall Med. 2012 Dec;33(7):E191-E195. doi: 10.1055/s-0031-1282029. Epub 2011 Dec 22.
4
Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography.肝门部胆管癌的强化模式:超声造影与 CT 造影的比较。
Eur J Radiol. 2010 Aug;75(2):197-202. doi: 10.1016/j.ejrad.2009.04.060. Epub 2009 May 22.
5
CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.320例肝细胞癌和肝内胆管细胞癌患者的对比增强超声检查——早期或晚期洗脱的重要性:DEGUM多中心试验的亚分析
Ultraschall Med. 2015 Apr;36(2):132-9. doi: 10.1055/s-0034-1399147. Epub 2015 Mar 26.
6
Contrast-enhanced ultrasound appearances of enhancement patterns of intrahepatic cholangiocarcinoma: correlation with pathological findings.肝内胆管细胞癌增强超声表现的增强模式:与病理发现的相关性。
Updates Surg. 2014 Jun;66(2):135-43. doi: 10.1007/s13304-014-0251-6. Epub 2014 May 7.
7
Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.肝内胆管细胞癌的超声造影:与病理检查的相关性。
Br J Radiol. 2012 Aug;85(1016):1029-37. doi: 10.1259/bjr/21653786. Epub 2012 Feb 28.
8
Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma.超声造影在肝内周围型胆管癌诊断中的价值
J Clin Ultrasound. 2011 Oct;39(8):447-53. doi: 10.1002/jcu.20797. Epub 2011 May 27.
9
Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.单发病灶患者肝内胆管癌(ICC)在超声造影(CEUS)上增强模式的影响因素及其病理相关性
Ultraschall Med. 2016 Dec;37(6):609-618. doi: 10.1055/s-0034-1399485. Epub 2015 Apr 28.
10
Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.使用低机械指数模式和六氟化硫填充微泡造影剂的超声造影对肝脏局灶性病变进行特征分析。
J Clin Ultrasound. 2006 Jul-Aug;34(6):261-72. doi: 10.1002/jcu.20234.

引用本文的文献

1
Diagnosis of intrahepatic cholangiocarcinoma with CEUS.超声造影诊断肝内胆管癌
J Ultrason. 2024 Feb 27;24(96):20240005. doi: 10.15557/jou.2024.0005. eCollection 2024 Feb.
2
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives.对比增强成像在肝内胆管癌管理中的应用:现状与未来展望
Cancers (Basel). 2023 Jun 28;15(13):3393. doi: 10.3390/cancers15133393.
3
Characteristics of hepatic solitary necrotic nodules on contrast-enhanced ultrasonography.超声造影检查对肝脏单发坏死性结节特征的分析。

本文引用的文献

1
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center.胆管癌:关于临床实践诊断和治疗算法的当前观点:文献综述及转诊中心的长期经验
Dig Liver Dis. 2016 Mar;48(3):231-41. doi: 10.1016/j.dld.2015.11.017. Epub 2015 Nov 28.
2
Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma.肝内胆管癌的临床诊断与分期。
J Gastrointestin Liver Dis. 2015 Dec;24(4):481-9. doi: 10.15403/jgld.2014.1121.244.chl.
3
Intrahepatic Cholangiocarcinoma.
BMC Gastroenterol. 2021 Jan 25;21(1):35. doi: 10.1186/s12876-021-01608-9.
肝内胆管癌
Tech Vasc Interv Radiol. 2015 Dec;18(4):227-35. doi: 10.1053/j.tvir.2015.07.006. Epub 2015 Jul 15.
4
Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline.超声造影在肝细胞癌和肝内胆管癌诊断中的应用:对美国肝脏病研究协会(ASLD)指南的争议
Biomed Res Int. 2015;2015:349172. doi: 10.1155/2015/349172. Epub 2015 May 18.
5
Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.对比增强超声对时间特征的详细分析可能有助于鉴别肝硬化患者肝内胆管癌与肝细胞癌。
PLoS One. 2014 May 29;9(5):e98612. doi: 10.1371/journal.pone.0098612. eCollection 2014.
6
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.肝内胆管癌诊断和管理指南
J Hepatol. 2014 Jun;60(6):1268-89. doi: 10.1016/j.jhep.2014.01.021. Epub 2014 Mar 27.
7
Cholangiocarcinoma.胆管癌。
Lancet. 2014 Jun 21;383(9935):2168-79. doi: 10.1016/S0140-6736(13)61903-0. Epub 2014 Feb 26.
8
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.肝硬化患者在超声造影下肝内胆管细胞癌的表现模式及误诊风险。
Liver Int. 2013 May;33(5):771-9. doi: 10.1111/liv.12124. Epub 2013 Feb 27.
9
Serum markers of intrahepatic cholangiocarcinoma.血清标志物在肝内胆管癌中的应用。
Dis Markers. 2013;34(4):219-28. doi: 10.3233/DMA-130964.
10
Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.肝脏对比增强超声(CEUS)指南和临床实践良好建议-2012 年更新:WFUMB-EFSUMB 与 AFSUMB、AIUM、ASUM、FLAUS 和 ICUS 的代表合作开展的一项倡议。
Ultrasound Med Biol. 2013 Feb;39(2):187-210. doi: 10.1016/j.ultrasmedbio.2012.09.002. Epub 2012 Nov 5.